Highlights
KLSE: APEX (5088)       APEX EQUITY HOLDINGS BHD MAIN : Finance
Last Price Today's Change   Day's Range   Trading Volume
0.92   -0.005 (0.54%)  0.915 - 0.93  54,600
Trade this stock for as low as 0.05% brokerage. Find out more.

Financials


Market Cap: 196 Million

Market Cap 196 Million
NOSH 214 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 31-Mar-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 31-Mar-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Sep-2020 [#3]

Latest Quarter: 30-Sep-2020 [#3]
Announcement Date 12-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 27-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   37.39%  |    594.24%

Annual (Unaudited) ( EPS: 2.81, P/E: 32.70 )

Revenue | NP to SH 33,998  |  6,009
RPS | P/RPS 15.92 Cent  |  5.78
EPS | P/E | EY 2.81 Cent  |  32.70  |  3.06%
DPS | DY | Payout % 1.90 Cent  |  2.07%  |  67.45%
NAPS | P/NAPS 1.41  |  0.65
YoY   -26.67%
NP Margin | ROE 17.67%  |  1.99%
F.Y. | Ann. Date 31-Dec-2019  |  27-Feb-2020

T4Q Result ( EPS: 6.66, P/E: 13.81 )

Revenue | NP to SH 49,177  |  14,225
RPS | P/RPS 23.03 Cent  |  4.00
EPS | P/E | EY 6.66 Cent  |  13.81  |  7.24%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 1.47  |  0.63
QoQ | YoY   58.65%  |    89.49%
NP Margin | ROE 28.93%  |  4.53%
F.Y. | Ann. Date 30-Sep-2020  |  12-Nov-2020

Annualized Result ( EPS: 7.98, P/E: 11.53 )

Revenue | NP to SH 54,372  |  17,036
RPS | P/RPS 25.46 Cent  |  3.61
EPS | P/E | EY 7.98 Cent  |  11.53  |  8.67%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   28.42%  |    180.14%
NP Margin | ROE 31.33%  |  5.42%
F.Y. | Ann. Date 30-Sep-2020  |  12-Nov-2020




Show?  YoY % Horiz. %

Last 10 FY Result
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 54,372 49,177 33,998 40,789 43,878 36,727 45,923 72,203 68,056 47,376 51,369 47,723 -3.70%
  YoY % 10.56% 44.65% -16.65% -7.04% 19.47% -20.02% -36.40% 6.09% 43.65% -7.77% 7.64% -
  Horiz. % 113.93% 103.05% 71.24% 85.47% 91.94% 76.96% 96.23% 151.30% 142.61% 99.27% 107.64% 100.00%
PBT 22,625 19,363 9,478 11,307 18,414 14,438 22,127 34,733 31,165 29,780 23,504 18,676 -7.26%
  YoY % 16.85% 104.29% -16.18% -38.60% 27.54% -34.75% -36.29% 11.45% 4.65% 26.70% 25.85% -
  Horiz. % 121.15% 103.68% 50.75% 60.54% 98.60% 77.31% 118.48% 185.98% 166.87% 159.46% 125.85% 100.00%
Tax -5,589 -5,138 -3,469 -3,112 -4,374 -3,933 -3,709 -5,897 -5,738 -3,693 -5,148 -3,658 -0.59%
  YoY % -8.78% -48.11% -11.47% 28.85% -11.21% -6.04% 37.10% -2.77% -55.38% 28.26% -40.73% -
  Horiz. % 152.80% 140.46% 94.83% 85.07% 119.57% 107.52% 101.39% 161.21% 156.86% 100.96% 140.73% 100.00%
NP 17,036 14,225 6,009 8,195 14,040 10,505 18,418 28,836 25,427 26,087 18,356 15,018 -9.67%
  YoY % 19.76% 136.73% -26.67% -41.63% 33.65% -42.96% -36.13% 13.41% -2.53% 42.12% 22.23% -
  Horiz. % 113.44% 94.72% 40.01% 54.57% 93.49% 69.95% 122.64% 192.01% 169.31% 173.70% 122.23% 100.00%
NP to SH 17,036 14,225 6,009 8,195 14,040 10,505 18,418 28,836 25,427 26,087 18,356 15,018 -9.67%
  YoY % 19.76% 136.73% -26.67% -41.63% 33.65% -42.96% -36.13% 13.41% -2.53% 42.12% 22.23% -
  Horiz. % 113.44% 94.72% 40.01% 54.57% 93.49% 69.95% 122.64% 192.01% 169.31% 173.70% 122.23% 100.00%
Tax Rate 24.70 % 26.54 % 36.60 % 27.52 % 23.75 % 27.24 % 16.76 % 16.98 % 18.41 % 12.40 % 21.90 % 19.59 % 7.19%
  YoY % -6.93% -27.49% 32.99% 15.87% -12.81% 62.53% -1.30% -7.77% 48.47% -43.38% 11.79% -
  Horiz. % 126.08% 135.48% 186.83% 140.48% 121.24% 139.05% 85.55% 86.68% 93.98% 63.30% 111.79% 100.00%
Total Cost 37,336 34,952 27,989 32,594 29,838 26,222 27,505 43,367 42,629 21,289 33,013 32,705 -1.71%
  YoY % 6.82% 24.88% -14.13% 9.24% 13.79% -4.66% -36.58% 1.73% 100.24% -35.51% 0.94% -
  Horiz. % 114.16% 106.87% 85.58% 99.66% 91.23% 80.18% 84.10% 132.60% 130.34% 65.09% 100.94% 100.00%
Net Worth 314,091 314,091 301,933 299,907 289,775 285,726 285,691 291,804 285,673 267,569 284,446 296,197 0.21%
  YoY % 0.00% 4.03% 0.68% 3.50% 1.42% 0.01% -2.09% 2.15% 6.77% -5.93% -3.97% -
  Horiz. % 106.04% 106.04% 101.94% 101.25% 97.83% 96.46% 96.45% 98.52% 96.45% 90.33% 96.03% 100.00%
Dividend
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div - 0 4,052 - 4,052 10,132 10,130 24,317 16,208 42,567 8,185 6,213 -4.63%
  YoY % 0.00% 0.00% 0.00% 0.00% -60.00% 0.01% -58.34% 50.03% -61.92% 420.04% 31.73% -
  Horiz. % 0.00% 0.00% 65.22% 0.00% 65.22% 163.06% 163.04% 391.33% 260.84% 685.04% 131.73% 100.00%
Div Payout % - % - % 67.45 % - % 28.87 % 96.45 % 55.01 % 84.33 % 63.75 % 163.18 % 44.59 % 41.38 % 5.58%
  YoY % 0.00% 0.00% 0.00% 0.00% -70.07% 75.33% -34.77% 32.28% -60.93% 265.96% 7.76% -
  Horiz. % 0.00% 0.00% 163.00% 0.00% 69.77% 233.08% 132.94% 203.79% 154.06% 394.35% 107.76% 100.00%
Equity
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 314,091 314,091 301,933 299,907 289,775 285,726 285,691 291,804 285,673 267,569 284,446 296,197 0.21%
  YoY % 0.00% 4.03% 0.68% 3.50% 1.42% 0.01% -2.09% 2.15% 6.77% -5.93% -3.97% -
  Horiz. % 106.04% 106.04% 101.94% 101.25% 97.83% 96.46% 96.45% 98.52% 96.45% 90.33% 96.03% 100.00%
NOSH 202,640 202,640 202,640 202,640 202,640 202,643 202,618 202,642 202,605 202,703 204,637 207,131 -0.24%
  YoY % 0.00% 0.00% 0.00% 0.00% -0.00% 0.01% -0.01% 0.02% -0.05% -0.94% -1.20% -
  Horiz. % 97.83% 97.83% 97.83% 97.83% 97.83% 97.83% 97.82% 97.83% 97.82% 97.86% 98.80% 100.00%
Ratio Analysis
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 31.33 % 28.93 % 17.67 % 20.09 % 32.00 % 28.60 % 40.11 % 39.94 % 37.36 % 55.06 % 35.73 % 31.47 % -6.21%
  YoY % 8.30% 63.72% -12.05% -37.22% 11.89% -28.70% 0.43% 6.91% -32.15% 54.10% 13.54% -
  Horiz. % 99.56% 91.93% 56.15% 63.84% 101.68% 90.88% 127.45% 126.91% 118.72% 174.96% 113.54% 100.00%
ROE 5.42 % 4.53 % 1.99 % 2.73 % 4.85 % 3.68 % 6.45 % 9.88 % 8.90 % 9.75 % 6.45 % 5.07 % -9.86%
  YoY % 19.65% 127.64% -27.11% -43.71% 31.79% -42.95% -34.72% 11.01% -8.72% 51.16% 27.22% -
  Horiz. % 106.90% 89.35% 39.25% 53.85% 95.66% 72.58% 127.22% 194.87% 175.54% 192.31% 127.22% 100.00%
Per Share
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 26.83 24.27 16.78 20.13 21.65 18.12 22.66 35.63 33.59 23.37 25.10 23.04 -3.46%
  YoY % 10.55% 44.64% -16.64% -7.02% 19.48% -20.04% -36.40% 6.07% 43.73% -6.89% 8.94% -
  Horiz. % 116.45% 105.34% 72.83% 87.37% 93.97% 78.65% 98.35% 154.64% 145.79% 101.43% 108.94% 100.00%
EPS 8.41 7.02 2.97 4.04 6.93 5.18 9.09 14.23 12.55 12.87 8.97 7.25 -9.43%
  YoY % 19.80% 136.36% -26.49% -41.70% 33.78% -43.01% -36.12% 13.39% -2.49% 43.48% 23.72% -
  Horiz. % 116.00% 96.83% 40.97% 55.72% 95.59% 71.45% 125.38% 196.28% 173.10% 177.52% 123.72% 100.00%
DPS 0.00 0.00 2.00 0.00 2.00 5.00 5.00 12.00 8.00 21.00 4.00 3.00 -4.40%
  YoY % 0.00% 0.00% 0.00% 0.00% -60.00% 0.00% -58.33% 50.00% -61.90% 425.00% 33.33% -
  Horiz. % 0.00% 0.00% 66.67% 0.00% 66.67% 166.67% 166.67% 400.00% 266.67% 700.00% 133.33% 100.00%
NAPS 1.5500 1.5500 1.4900 1.4800 1.4300 1.4100 1.4100 1.4400 1.4100 1.3200 1.3900 1.4300 0.46%
  YoY % 0.00% 4.03% 0.68% 3.50% 1.42% 0.00% -2.08% 2.13% 6.82% -5.04% -2.80% -
  Horiz. % 108.39% 108.39% 104.20% 103.50% 100.00% 98.60% 98.60% 100.70% 98.60% 92.31% 97.20% 100.00%
Adjusted Per Share Value based on latest NOSH - 213,563
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 25.46 23.03 15.92 19.10 20.55 17.20 21.50 33.81 31.87 22.18 24.05 22.35 -3.70%
  YoY % 10.55% 44.66% -16.65% -7.06% 19.48% -20.00% -36.41% 6.09% 43.69% -7.78% 7.61% -
  Horiz. % 113.91% 103.04% 71.23% 85.46% 91.95% 76.96% 96.20% 151.28% 142.60% 99.24% 107.61% 100.00%
EPS 7.98 6.66 2.81 3.84 6.57 4.92 8.62 13.50 11.91 12.22 8.60 7.03 -9.68%
  YoY % 19.82% 137.01% -26.82% -41.55% 33.54% -42.92% -36.15% 13.35% -2.54% 42.09% 22.33% -
  Horiz. % 113.51% 94.74% 39.97% 54.62% 93.46% 69.99% 122.62% 192.03% 169.42% 173.83% 122.33% 100.00%
DPS 0.00 0.00 1.90 0.00 1.90 4.74 4.74 11.39 7.59 19.93 3.83 2.91 -4.62%
  YoY % 0.00% 0.00% 0.00% 0.00% -59.92% 0.00% -58.38% 50.07% -61.92% 420.37% 31.62% -
  Horiz. % 0.00% 0.00% 65.29% 0.00% 65.29% 162.89% 162.89% 391.41% 260.82% 684.88% 131.62% 100.00%
NAPS 1.4707 1.4707 1.4138 1.4043 1.3569 1.3379 1.3377 1.3664 1.3377 1.2529 1.3319 1.3869 0.21%
  YoY % 0.00% 4.02% 0.68% 3.49% 1.42% 0.01% -2.10% 2.15% 6.77% -5.93% -3.97% -
  Horiz. % 106.04% 106.04% 101.94% 101.25% 97.84% 96.47% 96.45% 98.52% 96.45% 90.34% 96.03% 100.00%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date AQR T4Q 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 0.8700 0.8700 0.8000 0.9400 1.4300 1.4500 1.9000 1.4500 1.1700 1.1000 0.8400 0.7700 -
P/RPS 3.24 3.58 4.77 4.67 6.60 8.00 8.38 4.07 3.48 4.71 3.35 3.34 4.04%
  YoY % -9.50% -24.95% 2.14% -29.24% -17.50% -4.53% 105.90% 16.95% -26.11% 40.60% 0.30% -
  Horiz. % 97.01% 107.19% 142.81% 139.82% 197.60% 239.52% 250.90% 121.86% 104.19% 141.02% 100.30% 100.00%
P/EPS 10.35 12.39 26.98 23.24 20.64 27.97 20.90 10.19 9.32 8.55 9.36 10.62 10.91%
  YoY % -16.46% -54.08% 16.09% 12.60% -26.21% 33.83% 105.10% 9.33% 9.01% -8.65% -11.86% -
  Horiz. % 97.46% 116.67% 254.05% 218.83% 194.35% 263.37% 196.80% 95.95% 87.76% 80.51% 88.14% 100.00%
EY 9.66 8.07 3.71 4.30 4.85 3.58 4.78 9.81 10.73 11.70 10.68 9.42 -9.83%
  YoY % 19.70% 117.52% -13.72% -11.34% 35.47% -25.10% -51.27% -8.57% -8.29% 9.55% 13.38% -
  Horiz. % 102.55% 85.67% 39.38% 45.65% 51.49% 38.00% 50.74% 104.14% 113.91% 124.20% 113.38% 100.00%
DY 0.00 0.00 2.50 0.00 1.40 3.45 2.63 8.28 6.84 19.09 4.76 3.90 -4.82%
  YoY % 0.00% 0.00% 0.00% 0.00% -59.42% 31.18% -68.24% 21.05% -64.17% 301.05% 22.05% -
  Horiz. % 0.00% 0.00% 64.10% 0.00% 35.90% 88.46% 67.44% 212.31% 175.38% 489.49% 122.05% 100.00%
P/NAPS 0.56 0.56 0.54 0.64 1.00 1.03 1.35 1.01 0.83 0.83 0.60 0.54 -
  YoY % 0.00% 3.70% -15.62% -36.00% -2.91% -23.70% 33.66% 21.69% 0.00% 38.33% 11.11% -
  Horiz. % 103.70% 103.70% 100.00% 118.52% 185.19% 190.74% 250.00% 187.04% 153.70% 153.70% 111.11% 100.00%
Price Multiplier on Announcement Date
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date AQR T4Q 27/02/20 21/02/19 22/02/18 20/02/17 24/02/16 25/02/15 27/02/14 21/02/13 23/02/12 24/02/11 -
Price 0.9150 0.9150 0.7600 1.0000 1.4500 1.3600 1.8000 1.5000 1.2000 1.1000 0.8000 0.7700 -
P/RPS 3.41 3.77 4.53 4.97 6.70 7.50 7.94 4.21 3.57 4.71 3.19 3.34 3.44%
  YoY % -9.55% -16.78% -8.85% -25.82% -10.67% -5.54% 88.60% 17.93% -24.20% 47.65% -4.49% -
  Horiz. % 102.10% 112.87% 135.63% 148.80% 200.60% 224.55% 237.72% 126.05% 106.89% 141.02% 95.51% 100.00%
P/EPS 10.88 13.03 25.63 24.73 20.93 26.23 19.80 10.54 9.56 8.55 8.92 10.62 10.28%
  YoY % -16.50% -49.16% 3.64% 18.16% -20.21% 32.47% 87.86% 10.25% 11.81% -4.15% -16.01% -
  Horiz. % 102.45% 122.69% 241.34% 232.86% 197.08% 246.99% 186.44% 99.25% 90.02% 80.51% 83.99% 100.00%
EY 9.19 7.67 3.90 4.04 4.78 3.81 5.05 9.49 10.46 11.70 11.21 9.42 -9.33%
  YoY % 19.82% 96.67% -3.47% -15.48% 25.46% -24.55% -46.79% -9.27% -10.60% 4.37% 19.00% -
  Horiz. % 97.56% 81.42% 41.40% 42.89% 50.74% 40.45% 53.61% 100.74% 111.04% 124.20% 119.00% 100.00%
DY 0.00 0.00 2.63 0.00 1.38 3.68 2.78 8.00 6.67 19.09 5.00 3.90 -4.28%
  YoY % 0.00% 0.00% 0.00% 0.00% -62.50% 32.37% -65.25% 19.94% -65.06% 281.80% 28.21% -
  Horiz. % 0.00% 0.00% 67.44% 0.00% 35.38% 94.36% 71.28% 205.13% 171.03% 489.49% 128.21% 100.00%
P/NAPS 0.59 0.59 0.51 0.68 1.01 0.96 1.28 1.04 0.85 0.83 0.58 0.54 -0.63%
  YoY % 0.00% 15.69% -25.00% -32.67% 5.21% -25.00% 23.08% 22.35% 2.41% 43.10% 7.41% -
  Horiz. % 109.26% 109.26% 94.44% 125.93% 187.04% 177.78% 237.04% 192.59% 157.41% 153.70% 107.41% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  4 people like this.
 
SyedIbrahim Rumors say HK investor is taking position, may end up taking control of the company, it's time to buy in, fundamentally it's one of the most conservative broking house in the country, kosong borrowing with ample cash.....
23/10/2015 10:38 PM
SyedIbrahim Buy now before it's too late.
08/12/2015 10:20 PM
SyedIbrahim Buy before it's too late as there company more money than any other non bank backed stock brokers.
09/12/2015 8:44 PM
SyedIbrahim Buy up and reap profit 2.50
10/12/2015 9:25 PM
SyedIbrahim It's time to go in buy buy buy ....
21/01/2016 9:54 PM
leroy Any news?
12/08/2016 4:26 PM
fanchong no news?
20/09/2016 8:03 PM
ACE9696 ape cerita ? matilah matilah...
01/10/2016 1:22 PM
Jimmy Lim woohoooo.... TP0.900
11/10/2016 4:44 PM
Noni Why ?
11/10/2016 5:05 PM
Jimmy Lim coz price keep on droping
11/10/2016 5:18 PM
smartInvestor1 downtrend.. Should drop to 1.15. Apex can't compete with other broker. Property also not good.
21/01/2017 11:54 PM
ACE9696 apex vs genting
03/04/2017 1:11 AM
ACE9696 huhuhu... bck to normal
06/04/2017 1:11 AM
Amnota Interesting counter
25/06/2017 2:14 AM
James James just now done 1.76
07/09/2017 4:45 PM
James James already up 0,34
07/09/2017 4:45 PM
ACE9696 wulamak! tiba tiba
07/09/2017 11:37 PM
ACE9696 TP 3.000
08/09/2017 10:03 AM
chrispsng KUALA LUMPUR: Apex Equity Holdings Bhd saw 23% of its paid-up traded off-market at midday on Friday at RM2 each.

Stock market data showed that 49.77 million shares were crossed at RM2 each, which was 21 sen or 11.7% above Thursday's closing price of RM1.79.

At midday, the share price of the stockbroking company was up six sen to RM1.85.

In the second quarter ended June 30, 2017, its earnings rose 54% to RM3.84mil from the RM2.49mil a year ago.

In the first half, its earnings jumped 107% to RM8.35mil from RM4.02mil in the previous corresponding period.
TAGS / KEYWORDS:
Corporate News , Markets

Read more at http://www.thestar.com.my/business/business-news/2017/09/08/apex-equity-sees-23pct-stake-traded-off-market-at-rm2-each/#rO4UckZ2KpGFfm0g.99
08/09/2017 2:57 PM
Goldchia MH China company are buying up ? To 2.80?
08/09/2017 9:23 PM
Noni LOL! Chinaman or any person willing to buy 23% at 2.00 with bigger voting rights and controlling %.
Are you willing to even pay 2.00 for a 0.1% stake with no say?
08/09/2017 9:29 PM
ACE9696 kuat
05/03/2018 11:12 PM
daren drop so heavy today?
15/03/2018 10:15 AM
apolloang what happen another limit down?
15/03/2018 10:17 AM
nyapheng rebound
15/03/2018 11:01 AM
Jimmy Lim sapu
15/03/2018 12:09 PM
Syndicates insider trading
15/03/2018 12:14 PM
Sebastian Power kena margin call kot
15/03/2018 3:53 PM
Secret Hope to move up to 1.15 tomorrow
15/03/2018 4:56 PM
BlackWhite Hi, invest stock with own money not borrowed money, since is not sure win, lots ppl died on margin
16/03/2018 9:21 AM
Syndicates why top 30 holders dont feel stress when they are having paper loss?
16/03/2018 10:27 AM
bearguy Either Azizan or Lim Siew Kin dump the shares, since ex chairman no longer in position, no more reason to stay. Fundamental still intact.
16/03/2018 10:33 AM
leroy Down below RM1
26/04/2018 4:14 PM
ACE9696 wa lao eh
27/04/2018 1:15 AM
Buylowselllower Become shareholder of company again ! ! !
21/08/2018 3:39 PM
Michaelphlee Apex said it will pay RM22mil cash to Mercury Securities three days after the deal becomes unconditional. It will issue 100 million new shares at 92 sen each to Mercury Securities and pay the remaining RM26mil in cash to complete the deal.

To raise cash for the acquisition, Apex said it plans to place out 20 million new shares at a price to be determined at a later date. Mercury Securities will end up with a 31% stake in the enlarged Apex Equity group.


Read more at https://www.thestar.com.my/business/business-news/2018/09/21/apex-equity-to-merge-with-mercury-securities/#2FpuHfOBll1kjoii.99
21/09/2018 9:13 PM
Buylowselllower Sold out all my holding share, merger with other company, issue new share, private placement share, I feel no good as a shareholder. About PE 15 is a high price for me,probably my business sense not good as BOD.
24/09/2018 11:41 AM
afterlight PE 15 for a sun-setting stockbroking business... use the money to invest banking stock like PBB and Maybank better...
26/09/2018 12:19 PM
Michaelphlee Looks like purposely suppress the price. SC should investigate.
29/09/2018 6:02 PM
leroy Limit up
03/10/2018 3:11 PM
dompeilee Hmmm...recommended to my paying subscribers when it dropped sharply in March...then decided 2 put my $ where my mouth was & bought some @ 1.0533...

Was so disappointed when they wanted to issue shares @ 92c lately...

Now....=)))
03/10/2018 4:06 PM
zhen wei & JP congratulation dompei. kaya sudah.....


@afterlight,
not all fund have such capability to absorb. 10 out of 3 only succed to retain their exisiting fund.
so far i meet few great manager like Lee.S.Y , See.Y.H . AUM /5 billion above.
last month cimb sold thier APAC<< they probably forsee going to be tough days ahead.

sunset industry to be? :(
03/10/2018 6:36 PM
Michaelphlee 13.02.2019- “the Board of Directors of the Company, AIBB wishes to announce that Apex, JF Apex and Mercury Securities had mutually agreed to extend the Due Diligence Period until 18 March 2019.” Don’t feel good.
13/02/2019 9:51 PM
Nickychung Post removed. Why?
06/11/2019 2:02 PM
YAPSS YAPSS Quick Summary of Apex Equity Holdings Berhad:
https://www.yapss.com/forum/klse-forum/apex-equity-holdings-berhad-apex-5088
06/12/2019 7:06 PM
mf https://www.theedgemarkets.com/article/apex-healthcare-may-rise-higher-says-rhb-retail-research-0
15/05/2020 8:23 AM
vatbitrage technical analysis upawing
20/05/2020 1:44 PM
gick891214 Tomorrow limit up again
22/07/2020 9:27 PM
NPRA1985 China's Sinopharm says data 'better than expected' from it's COVID vaccine trial

https://www.livemint.com/companies/news/china-s-sinopharm-says-data-better-than-expected-from-it-s-covid-vaccine-trial-11605100199684.html
13/11/2020 5:10 PM